{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T21:36:50Z","timestamp":1782164210225,"version":"3.54.5"},"reference-count":251,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,6]]},"DOI":"10.1097\/ogx.0b013e31828aca19","type":"journal-article","created":{"date-parts":[[2013,5,23]],"date-time":"2013-05-23T18:41:38Z","timestamp":1369334498000},"page":"445-466","source":"Crossref","is-referenced-by-count":139,"title":["Current Concepts and New Trends in the Diagnosis and Management of Recurrent Miscarriage"],"prefix":"10.1097","volume":"68","author":[{"given":"Jaume","family":"Alijotas-Reig","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Garrido-Gimenez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-19-20210212","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1093\/humrep\/17.2.446","article-title":"Cytogenetic analysis of miscarriages from couples with recurrent miscarriage: a case-control study.","volume":"17","author":"Stephenson","year":"2002","journal-title":"Hum Reprod"},{"key":"R2-19-20210212","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/S0140-6736(06)69204-0","article-title":"Recurrent miscarriage.","volume":"368","author":"Rai","year":"2006","journal-title":"Lancet"},{"key":"R3-19-20210212","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1056\/NEJM198807283190401","article-title":"Incidence of early loss of pregnancy.","volume":"319","author":"Wilcox","year":"1988","journal-title":"N Engl J Med"},{"key":"R4-19-20210212","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1055\/s-0037-1616243","article-title":"The epidemiology of venous thromboembolism in the community.","volume":"86","author":"Heit","year":"2001","journal-title":"Thromb Haemost"},{"key":"R5-19-20210212","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1157\/13080830","article-title":"Recurrent miscarriage and inherited thrombophilia: diagnostic work-out and therapeutic management.","volume":"125","author":"Alijotas-Reig","year":"2005","journal-title":"Med Clin (Barc)"},{"key":"R6-19-20210212","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1111\/j.1600-0897.1991.tb01077.x","article-title":"Immunotherapy for recurrent spontaneous abortion and its analogies to treatment for cancer.","volume":"25","author":"Coulam","year":"1991","journal-title":"Am J Reprod Immunol"},{"key":"R7-19-20210212","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1097\/01.gco.0000194112.86051.26","article-title":"Recurrent miscarriage: pathophysiology and outcome.","volume":"17","author":"Carrington","year":"2005","journal-title":"Curr Opin Obstet Gynecol"},{"key":"R8-19-20210212","doi-asserted-by":"crossref","first-page":"S60","DOI":"10.1016\/j.fertnstert.2008.08.065","article-title":"Definitions of infertility and recurrent pregnancy loss.","volume":"90","year":"2008","journal-title":"Fertil Steril"},{"key":"R9-19-20210212","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1016\/j.fertnstert.2009.01.166","article-title":"Diagnostic factors identified in 1020 women with two versus three or more recurrent pregnancy losses.","volume":"93","author":"Jaslow","year":"2010","journal-title":"Fertil Steril"},{"key":"R10-19-20210212","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1016\/S0140-6736(98)10265-9","article-title":"Thrombosis in pregnancy: maternal and fetal issues.","volume":"353","author":"Greer","year":"1999","journal-title":"Lancet"},{"key":"R11-19-20210212","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.thromres.2009.07.012","article-title":"Innate immunity, coagulation and placenta-related adverse pregnancy outcomes.","volume":"124","author":"Li","year":"2009","journal-title":"Thromb Res"},{"key":"R12-19-20210212","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1055\/s-0031-1293200","article-title":"First trimester miscarriage evaluation.","volume":"29","author":"Lathi","year":"2011","journal-title":"Semin Reprod Med"},{"key":"R13-19-20210212","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/S0015-0282(99)00495-1","article-title":"Embryonic karyotype of abortuses in relation to the number of previous miscarriages.","volume":"73","author":"Ogasawara","year":"2000","journal-title":"Fertil Steril"},{"key":"R14-19-20210212","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1093\/humrep\/deg309","article-title":"Embryoscopic and cytogenetic analysis of 233 missed abortions: factors involved in the pathogenesis of developmental defects of early failed pregnancies.","volume":"18","author":"Philipp","year":"2003","journal-title":"Hum Reprod"},{"key":"R15-19-20210212","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1097\/01.AOG.0000137832.86727.e2","article-title":"Recurrent fetal aneuploidy and recurrent miscarriage.","volume":"104","author":"Sullivan","year":"2004","journal-title":"Obstet Gynecol"},{"key":"R16-19-20210212","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1097\/01.GIM.0000160075.96707.04","article-title":"Incidence and spectrum of chromosome abnormalities in spontaneous abortions: new insights from a 12-year study.","volume":"7","author":"Menasha","year":"2005","journal-title":"Genet Med"},{"key":"R17-19-20210212","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1111\/j.1600-0897.2005.00260.x","article-title":"Embryo aneuploidy screening for unexplained recurrent miscarriage: a minireview.","volume":"53","author":"Rubio","year":"2005","journal-title":"Am J Reprod Immunol"},{"key":"R18-19-20210212","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1056\/NEJMcp1005330","article-title":"Clinical practice. Recurrent miscarriage.","volume":"363","author":"Branch","year":"2010","journal-title":"N Engl J Med"},{"key":"R19-19-20210212","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1097\/MED.0b013e328332b808","article-title":"Recurrent second trimester pregnancy loss: evaluation and management.","volume":"16","author":"Dukhovny","year":"2009","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"R20-19-20210212","first-page":"896","article-title":"Frequency of chromosomal aberrations in material from abortions.","volume":"81","author":"Kwinecka-Dmitriew","year":"2010","journal-title":"Ginekol Pol"},{"key":"R21-19-20210212","first-page":"681","article-title":"Do chromosomal abnormalities reappear in subsequent pregnancies and how often Ginekol Pol.","volume":"81","author":"Skrzypczak","year":"2010","journal-title":""},{"key":"R22-19-20210212","first-page":"519","article-title":"Cytogenetic studies in couples experiencing repeated pregnancy losses. Hum.","volume":"5","author":"De Braekeleer","year":"1990","journal-title":"Reprod"},{"key":"R24-19-20210212","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1055\/s-2006-931797","article-title":"Genetics of recurrent pregnancy loss.","volume":"24","author":"Sierra","year":"2006","journal-title":"Semin Reprod Med"},{"key":"R25-19-20210212","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1159\/000147170","article-title":"Chromosomal abnormalities in couples with reproductive disorders.","volume":"66","author":"Meza-Espinoza","year":"2008","journal-title":"Gynecol Obstet Invest"},{"key":"R26-19-20210212","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1136\/bmj.38498.669595.8F","article-title":"Selective chromosome analysis in couples with two or more miscarriages: case-control study.","volume":"331","author":"Franssen","year":"2005","journal-title":"BMJ"},{"key":"R27-19-20210212","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1007\/BF00285027","article-title":"Chromosome anomalies in 136 couples with a history of recurrent abortions.","volume":"65","author":"Diedrich","year":"1983","journal-title":"Hum Genet"},{"key":"R28-19-20210212","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1007\/s10038-008-0290-2","article-title":"Subsequent pregnancy outcomes in recurrent miscarriage patients with a paternal or maternal carrier of a structural chromosome rearrangement.","volume":"53","author":"Sugiura-Ogasawara","year":"2008","journal-title":"J Hum Genet"},{"key":"R29-19-20210212","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.fertnstert.2005.07.1305","article-title":"Embryonic karyotype in recurrent miscarriage with parental karyotypic aberrations.","volume":"85","author":"Carp","year":"2006","journal-title":"Fertil Steril"},{"key":"R30-19-20210212","first-page":"1411","article-title":"Consecutive or non-consecutive recurrent miscarriage: is there any difference in carrier status Hum Reprod.","volume":"25","author":"van den Boogaard","year":"2010","journal-title":""},{"key":"R31-19-20210212","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.thromres.2008.09.017","article-title":"Low protein Z levels, but not the intron F G79A polymorphism, are associated with unexplained pregnancy loss.","volume":"124","author":"Topalidou","year":"2009","journal-title":"Thromb Res"},{"key":"R32-19-20210212","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1111\/j.1600-0897.2008.00659.x","article-title":"The association of apoprotein E polymorphisms with recurrent pregnancy loss.","volume":"61","author":"Goodman","year":"2009","journal-title":"Am J Reprod Immunol"},{"key":"R33-19-20210212","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/j.1600-0897.2009.00765.x","article-title":"STAT3 polymorphisms linked with idiopathic recurrent miscarriages.","volume":"63","author":"Finan","year":"2010","journal-title":"Am J Reprod Immunol"},{"key":"R34-19-20210212","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1387\/ijdb.082613pl","article-title":"Identification of quantitative trait loci responsible for embryonic lethality in mice assessed by ultrasonography.","volume":"53","author":"Laissue","year":"2009","journal-title":"Int J Dev Biol"},{"key":"R35-19-20210212","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1093\/humupd\/dmr027","article-title":"Genetic association studies of angiogenesis- and vasoconstriction-related genes in women with recurrent pregnancy loss: a systematic review and meta-analysis.","volume":"17","author":"Su","year":"2011","journal-title":"Hum Reprod Update"},{"key":"R36-19-20210212","doi-asserted-by":"crossref","first-page":"2664","DOI":"10.1093\/humrep\/deq211","article-title":"Genetic variation within the hypothalamus-pituitary-ovarian axis in women with recurrent miscarriage.","volume":"25","author":"Hanna","year":"2010","journal-title":"Hum Reprod"},{"key":"R37-19-20210212","doi-asserted-by":"crossref","first-page":"e10287","DOI":"10.1371\/journal.pone.0010287","article-title":"Natural selection of human embryos: impaired decidualization of endometrium disables embryo-maternal interactions and causes recurrent pregnancy loss.","volume":"5","author":"Salker","year":"2010","journal-title":"PLoS One"},{"key":"R38-19-20210212","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/j.urology.2011.05.049","article-title":"Semen parameters and sperm DNA fragmentation as causes of recurrent pregnancy loss.","volume":"78","author":"Brahem","year":"2011","journal-title":"Urology"},{"key":"R39-19-20210212","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.molmed.2007.05.005","article-title":"Recurrent pregnancy loss: the key potential mechanisms.","volume":"13","author":"Baek","year":"2007","journal-title":"Trends Mol Med"},{"key":"R40-19-20210212","first-page":"365","article-title":"Glycemic thresholds in spontaneous abortion during the first trimester in pregnant women with insulin dependent diabetes.","volume":"49","author":"Mello","year":"1997","journal-title":"Minerva Ginecol"},{"key":"R41-19-20210212","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1056\/NEJM198812223192501","article-title":"Incidence of spontaneous abortion among normal women and insulin-dependent diabetic women whose pregnancies were identified within 21 days of conception.","volume":"319","author":"Mills","year":"1988","journal-title":"N Engl J Med"},{"key":"R42-19-20210212","first-page":"16","article-title":"K, Mazne\u012dkova V, Ivanov S, et al. Role of glycemic control and incidence of spontaneous abortions pregnant in women with type 1 diabetes mellitus.","volume":"43","year":"2004","journal-title":"Akush Ginekol"},{"key":"R43-19-20210212","first-page":"272","article-title":"Evaluation of the relationship between insulin resistance and recurrent pregnancy loss.","volume":"82","author":"Celik","year":"2011","journal-title":"Ginekol Pol"},{"key":"R44-19-20210212","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1159\/000325165","article-title":"Relationship between recurrent miscarriage and insulin resistance.","volume":"72","author":"Wang","year":"2011","journal-title":"Gynecol Obstet Invest"},{"key":"R45-19-20210212","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.2337\/diacare.28.5.1113","article-title":"Elevated pregnancy losses at high and low extremes of maternal glucose in early normal and diabetic pregnancy: evidence for a protective adaptation in diabetes.","volume":"28","author":"Jovanovic","year":"2005","journal-title":"Diabetes Care"},{"key":"R46-19-20210212","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1089\/thy.2011.0087","article-title":"American Thyroid Association Taskforce on Thyroid Disease During Pregnancy and Postpartum. Guidelines of the American Thyroid Association for the diagnosis and management of thyroid disease during pregnancy and postpartum.","volume":"21","author":"Stagnaro-Green","year":"2011","journal-title":"Thyroid"},{"key":"R47-19-20210212","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1093\/humupd\/dmr024","article-title":"Significance of (sub)clinical thyroid dysfunction and thyroid autoimmunity before conception and in early pregnancy: a systematic review.","volume":"17","author":"van den Boogaard","year":"2011","journal-title":"Hum Reprod Update"},{"key":"R48-19-20210212","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1089\/105072502753451986","article-title":"Overt and subclinical hypothyroidism complicating pregnancy.","volume":"12","author":"Abalovich","year":"2002","journal-title":"Thyroid"},{"key":"R49-19-20210212","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1080\/09513590701259542","article-title":"Clinical hypothyroidism and thyroid autoimmunity in women with infertility.","volume":"23","author":"Abalovich","year":"2007","journal-title":"Gynecol Endocrinol"},{"key":"R50-19-20210212","doi-asserted-by":"crossref","first-page":"294","DOI":"10.14310\/horm.2002.1210","article-title":"Thyroid autoimmunity and miscarriage.","volume":"7","author":"Kaprara","year":"2008","journal-title":"Hormones (Athens)"},{"key":"R51-19-20210212","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.1210\/jc.2005-1603","article-title":"Levothyroxine treatment in euthyroid pregnant women with autoimmune thyroid disease: effects on obstetrical complications.","volume":"91","author":"Negro","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"R52-19-20210212","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1097\/01.AOG.0000197991.64246.9a","article-title":"Subclinical hyperthyroidism and pregnancy outcomes.","volume":"107","author":"Casey","year":"2006","journal-title":"Obstet Gynecol"},{"key":"R53-19-20210212","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1530\/EJE-08-0953","article-title":"Higher maternal TSH levels in pregnancy are associated with increased risk for miscarriage, fetal or neonatal death.","volume":"160","author":"Benhadi","year":"2009","journal-title":"Eur J Endocrinol"},{"key":"R54-19-20210212","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1089\/thy.2010.0058","article-title":"Maternal thyroid function at 11 to 13 weeks of gestation and subsequent fetal death.","volume":"20","author":"Ashoor","year":"2010","journal-title":"Thyroid"},{"key":"R55-19-20210212","doi-asserted-by":"crossref","first-page":"E44","DOI":"10.1210\/jc.2010-0340","article-title":"Increased pregnancy loss rate in thyroid antibody negative women with TSH levels between 2.5 and 5.0 in the first trimester of pregnancy.","volume":"95","author":"Negro","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"R56-19-20210212","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1111\/j.1600-0897.2004.00215.x","article-title":"Anti-thyroid antibodies and antiphospholipid syndrome: evidence of reduced fecundity and of poor pregnancy outcome in recurrent spontaneous aborters.","volume":"52","author":"De Carolis","year":"2004","journal-title":"Am J Reprod Immunol"},{"key":"R57-19-20210212","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1177\/0961203310373781","article-title":"Prolactins role in the pathogenesis of the antiphospholipid syndrome.","volume":"19","author":"Praprotnik","year":"2010","journal-title":"Lupus"},{"key":"R58-19-20210212","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1093\/humrep\/deh350","article-title":"Lack of expression of endometrial prolactin in early implantation failure: a pilot study.","volume":"19","author":"Garzia","year":"2004","journal-title":"Hum Reprod"},{"key":"R59-19-20210212","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/humrep\/deh098","article-title":"Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome.","volume":"19","year":"2004","journal-title":"Hum Reprod"},{"key":"R60-19-20210212","first-page":"572","article-title":"How common is polycystic ovary syndrome in recurrent miscarriage Reprod Biomed Online.","volume":"19","author":"Cocksedge","year":"2009","journal-title":""},{"key":"R61-19-20210212","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S1472-6483(10)60304-5","article-title":"A reappraisal of the role of polycystic ovary syndrome in recurrent miscarriage.","volume":"17","author":"Cocksedge","year":"2008","journal-title":"Reprod Biomed Online"},{"key":"R62-19-20210212","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.ogc.2004.08.007","article-title":"Luteal phase defect: myth or reality.","volume":"31","author":"Bukulmez","year":"2004","journal-title":"Obstet Gynecol Clin North Am"},{"key":"R63-19-20210212","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/0140-6736(90)92765-A","article-title":"Hypersecretion of luteinising hormone, infertility, and miscarriage.","volume":"336","author":"Regan","year":"1990","journal-title":"Lancet"},{"key":"R64-19-20210212","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1093\/oxfordjournals.humrep.a138312","article-title":"Hypersecretion of luteinizing hormone (LH) and ovarian steroids in women with recurrent abortion.","volume":"9","author":"van Hooff","year":"1994","journal-title":"Hum Reprod"},{"key":"R65-19-20210212","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1136\/bmj.312.7045.1508","article-title":"Does suppressing luteinising hormone secretion reduce the miscarriage rate Results of a randomized controlled trial.","volume":"312","author":"Clifford","year":"1996","journal-title":"BMJ"},{"key":"R66-19-20210212","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.gyobfe.2012.01.004","article-title":"Nutrition and miscarriages: a literature review.","volume":"40","author":"Benammar","year":"2012","journal-title":"Gynecol Obstet Fertil"},{"key":"R67-19-20210212","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1111\/j.1467-842X.2000.tb01604.x","article-title":"Cigarette smoking, menstrual symptoms and miscarriage among young women.","volume":"24","author":"Mishra","year":"2000","journal-title":"Aust N Z J Public Health"},{"key":"R68-19-20210212","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1034\/j.1600-0412.2003.00078.x","article-title":"Cigarette, alcohol, and caffeine consumption: risk factors for spontaneous abortion.","volume":"82","author":"Rasch","year":"2003","journal-title":"Acta Obstet Gynecol Scand"},{"key":"R69-19-20210212","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1055\/s-0031-1293204","article-title":"Does obesity increase the risk of miscarriage in spontaneous conception: a systematic review.","volume":"29","author":"Boots","year":"2011","journal-title":"Semin Reprod Med"},{"key":"R70-19-20210212","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.1093\/humrep\/deh423","article-title":"Complex malformations of the female genital tract. New types and revision of classification.","volume":"19","author":"Acien","year":"2004","journal-title":"Hum Reprod"},{"key":"R71-19-20210212","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1055\/s-2006-931798","article-title":"Anatomic factors in recurrent pregnancy loss.","volume":"24","author":"Devi Wold","year":"2006","journal-title":"Semin Reprod Med"},{"key":"R72-19-20210212","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1093\/humupd\/dmn018","article-title":"Prevalence and diagnosis of congenital uterine anomalies in women with reproductive failure: a critical appraisal.","volume":"14","author":"Saravelos","year":"2008","journal-title":"Hum Reprod Update"},{"key":"R73-19-20210212","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0015-0282(99)00480-X","article-title":"The septate uterus: a review of management and reproductive outcome.","volume":"73","author":"Homer","year":"2000","journal-title":"Fertil Steril"},{"key":"R74-19-20210212","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1093\/humupd\/7.2.161","article-title":"Clinical implications of uterine malformations and hysteroscopic treatment results.","volume":"7","author":"Grimbizis","year":"2001","journal-title":"Hum Reprod Update"},{"key":"R75-19-20210212","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1097\/GCO.0b013e32814b0649","article-title":"Reproductive performance of women with mullerian anomalies.","volume":"19","author":"Rackow","year":"2007","journal-title":"Curr Opin Obstet Gynecol"},{"key":"R76-19-20210212","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.rbmo.2009.11.021","article-title":"The pattern of pregnancy loss in women with congenital uterine anomalies and recurrent miscarriage.","volume":"20","author":"Saravelos","year":"2010","journal-title":"Reprod Biomed Online"},{"key":"R77-19-20210212","first-page":"684","article-title":"Hysteroscopically detected asymptomatic mullerian anomalies. Prevalence and reproductive implications.","volume":"40","author":"Maneschi","year":"1995","journal-title":"J Reprod Med"},{"key":"R78-19-20210212","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1055\/s-0031-1293205","article-title":"Uterine anomaly and recurrent pregnancy loss.","volume":"29","author":"Sugiura-Ogasawara","year":"2011","journal-title":"Semin Reprod Med"},{"key":"R79-19-20210212","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1093\/humupd\/dmr028","article-title":"The prevalence of congenital uterine anomalies in unselected and high-risk populations: a systematic review.","volume":"17","author":"Chan","year":"2011","journal-title":"Hum Reprod Update"},{"key":"R80-19-20210212","doi-asserted-by":"crossref","first-page":"2628","DOI":"10.1093\/humrep\/dei081","article-title":"Hysteroscopy may be justified after two miscarriages.","volume":"20","author":"Weiss","year":"2005","journal-title":"Hum Reprod"},{"key":"R81-19-20210212","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.rbmo.2010.04.016","article-title":"Hysteroscopic findings in women with two and with more than two first-trimester miscarriages are not significantly different.","volume":"21","author":"Bohlmann","year":"2010","journal-title":"Reprod Biomed Online"},{"key":"R82-19-20210212","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S0104-4230(11)70084-7","article-title":"Office hysteroscopy study in consecutive miscarriage patients.","volume":"57","author":"Souza","year":"2011","journal-title":"Rev Assoc Med Bras"},{"key":"R83-19-20210212","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1097\/GRF.0b013e31802f11f6","article-title":"Causes of fetal wastage.","volume":"50","author":"Simpson","year":"2007","journal-title":"Clin Obstet Gynecol"},{"key":"R84-19-20210212","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1093\/humupd\/6.6.614","article-title":"Fibroids, infertility and pregnancy wastage.","volume":"6","author":"Bajekal","year":"2000","journal-title":"Hum Reprod Update"},{"key":"R85-19-20210212","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1093\/humrep\/16.11.2411","article-title":"A prospective controlled study of the effect of intramural uterine fibroids on the outcome of assisted conception.","volume":"16","author":"Hart","year":"2001","journal-title":"Hum Reprod"},{"key":"R86-19-20210212","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1080\/09513590600604673","article-title":"Effects of the position of fibroids on fertility.","volume":"22","author":"Casini","year":"2006","journal-title":"Gynecol Endocrinol"},{"key":"R87-19-20210212","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.ajog.2007.12.039","article-title":"Fibroids and reproductive outcomes: a systematic literature review from conception to delivery.","volume":"198","author":"Klatsky","year":"2008","journal-title":"Am J Obstet Gynecol"},{"key":"R88-19-20210212","doi-asserted-by":"crossref","first-page":"3274","DOI":"10.1093\/humrep\/der293","article-title":"The prevalence and impact of fibroids and their treatment on the outcome of pregnancy in women with recurrent miscarriage.","volume":"26","author":"Saravelos","year":"2011","journal-title":"Hum Reprod"},{"key":"R89-19-20210212","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1002\/jcu.1031","article-title":"Outcome of pregnancies in women with uterine leiomyomas identified by sonography in the first trimester.","volume":"29","author":"Benson","year":"2001","journal-title":"J Clin Ultrasound"},{"key":"R90-19-20210212","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1093\/humupd\/8.5.463","article-title":"Recurrent miscarriage: aetiology, management and prognosis.","volume":"8","author":"Li","year":"2002","journal-title":"Hum Reprod Update"},{"key":"R91-19-20210212","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1111\/j.1471-0528.2000.tb11670.x","article-title":"Endocrinological and endometrial factors in recurrent miscarriage.","volume":"107","author":"Li","year":"2000","journal-title":"BJOG"},{"key":"R92-19-20210212","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1093\/humupd\/8.1.43","article-title":"Endometrial factors in recurrent miscarriage.","volume":"8","author":"Li","year":"2002","journal-title":"Hum Reprod Update"},{"key":"R93-19-20210212","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1055\/s-0031-1293203","article-title":"Clinical assessment and management of the endometrium in recurrent early pregnancy loss.","volume":"29","author":"Patel","year":"2011","journal-title":"Semin Reprod Med"},{"key":"R94-19-20210212","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1093\/humupd\/dms006","article-title":"Adenomyosis and subfertility: a systematic review of prevalence, diagnosis, treatment and fertility outcomes.","volume":"18","author":"Maheshwari","year":"2012","journal-title":"Hum Reprod Update"},{"key":"R95-19-20210212","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.jri.2011.12.001","article-title":"The distribution of immune cells and macrophages in the endometrium of women with recurrent reproductive failure. II: Adenomyosis and macrophages.","volume":"93","author":"Tremellen","year":"2012","journal-title":"J Reprod Immunol"},{"key":"R96-19-20210212","first-page":"CD008991","article-title":"Cervical stitch (cerclage) for preventing preterm birth in singleton pregnancy.","volume":"4","author":"Alfirevic","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"R97-19-20210212","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1016\/S0140-6736(12)60030-0","article-title":"Cervical pessary in pregnant women with a short cervix (PECEP): an open-label randomised controlled trial.","volume":"379","author":"Goya","year":"2012","journal-title":"Lancet"},{"key":"R98-19-20210212","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1093\/humrep\/deh822","article-title":"Endometrial polyps and their implication in the pregnancy rates of patients undergoing intrauterine insemination: a prospective, randomized study.","volume":"20","author":"Perez-Medina","year":"2005","journal-title":"Hum Reprod"},{"key":"R99-19-20210212","doi-asserted-by":"crossref","first-page":"983","DOI":"10.3109\/14767058.2010.547963","article-title":"Role of the infections in recurrent spontaneous abortion.","volume":"24","author":"Nigro","year":"2011","journal-title":"J Matern Fetal Neonatal Med"},{"key":"R100-19-20210212","first-page":"684","article-title":"Seroanalysis of Chlamydia trachomatis and S-TORCH agents in women with recurrent spontaneous abortions.","volume":"46","author":"Kishore","year":"2003","journal-title":"Indian J Pathol Microbiol"},{"key":"R101-19-20210212","doi-asserted-by":"crossref","first-page":"86","DOI":"10.2478\/v10039-009-0008-5","article-title":"The influence of Chlamydia trachomatis infection on spontaneous abortions.","volume":"54","author":"Wilkowska-Trojniel","year":"2009","journal-title":"Adv Med Sci"},{"key":"R102-19-20210212","doi-asserted-by":"crossref","first-page":"115","DOI":"10.3109\/14647273.2010.513893","article-title":"Impact of Chlamydia trachomatis in the reproductive setting: British Fertility Society Guidelines for practice.","volume":"13","author":"Akande","year":"2010","journal-title":"Hum Fertil (Camb)"},{"key":"R103-19-20210212","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1126\/science.270.5236.630","article-title":"T cell awareness of paternal alloantigens during pregnancy.","volume":"270","author":"Tafuri","year":"1995","journal-title":"Science"},{"key":"R104-19-20210212","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.jri.2005.01.003","article-title":"CD4()CD25 T regulatory cells in murine pregnancy.","volume":"65","author":"Zenclussen","year":"2005","journal-title":"J Reprod Immunol"},{"key":"R105-19-20210212","doi-asserted-by":"crossref","first-page":"175","DOI":"10.2174\/157339509788921238","article-title":"Immunological puzzle related to recurrent miscarriage: overview.","volume":"5","author":"Alijotas-Reig","year":"2009","journal-title":"Curr Immunol Rev"},{"key":"R106-19-20210212","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/S0002-9440(10)62302-4","article-title":"Abnormal T-cell reactivity against paternal antigens in spontaneous abortion: adoptive transfer of pregnancy-induced CD4CD25 T regulatory cells prevents fetal rejection in a murine abortion model.","volume":"166","author":"Zenclussen","year":"2005","journal-title":"Am J Pathol"},{"key":"R107-19-20210212","doi-asserted-by":"crossref","first-page":"4875","DOI":"10.4049\/jimmunol.175.8.4875","article-title":"Protection from abortion by heme oxygenase-1 up-regulation is associated with increased levels of Bag-1 and neuropilin-1 at the fetal-maternal interface.","volume":"175","author":"Sollwedel","year":"2005","journal-title":"J Immunol"},{"key":"R108-19-20210212","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1056\/NEJM197611252952201","article-title":"Maternal-fetal relation. Absence of an immunologic blocking factor from the serum of women with chronic abortions.","volume":"295","author":"Rocklin","year":"1976","journal-title":"N Engl J Med"},{"key":"R109-19-20210212","doi-asserted-by":"crossref","first-page":"4903","DOI":"10.4049\/jimmunol.152.10.4903","article-title":"Maternal anti-placental reactivity in natural, immunologically-mediated fetal resorptions.","volume":"152","author":"Tangri","year":"1994","journal-title":"J Immunol"},{"key":"R110-19-20210212","first-page":"31","article-title":"Regulatory T cells in pregnancy.","volume":"28","author":"Zenclussen","year":"2006","journal-title":"Semin Imunol"},{"key":"R111-19-20210212","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1095\/biolreprod53.4.814","article-title":"Stress-induced murine abortion associated with substance P dependent alteration in cytokines in maternal uterine decidua.","volume":"53","author":"Arck","year":"1995","journal-title":"Biol Reprod"},{"key":"R112-19-20210212","first-page":"147","article-title":"Pregnancy protective T-reg are antigen-specific.","volume":"54","author":"Schumacher","year":"2005","journal-title":"Am J Reprod Immunol"},{"key":"R113-19-20210212","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1172\/JCI200420645","article-title":"Ovarian insufficiency and early pregnancy loss induced by activation of the innate immune system.","volume":"114","author":"Erlebacher","year":"2004","journal-title":"J Clin Invest"},{"key":"R114-19-20210212","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.jneuroim.2005.08.023","article-title":"Enhanced FoxP3 expression and T-reg cell function in pregnant and estrogen-treated mice.","volume":"170","author":"Polanczyk","year":"2005","journal-title":"J Neuroimmunol"},{"key":"R115-19-20210212","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1111\/j.1600-0897.1996.tb00056.x","article-title":"Enhancement of the expression of progesterone receptor on progesterone-treated lymphocytes after immunotherapy in unexplained recurrent spontaneous abortion.","volume":"35","author":"Chiu","year":"1996","journal-title":"Am J Reprod Immunol"},{"key":"R116-19-20210212","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1111\/j.1600-0897.1996.tb00492.x","article-title":"The immunological pregnancy protective effect of progesterone is manifested via controlling cytokine production.","volume":"35","author":"Szekeres-Bartho","year":"1996","journal-title":"Am J Reprod Immunol"},{"key":"R117-19-20210212","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1034\/j.1600-0897.2003.01149.x","article-title":"Progesterone regulates IL12 expression in pregnancy lymphocytes by inhibiting phospholipase A2.","volume":"49","author":"Par","year":"2003","journal-title":"Am J Reprod Immunol"},{"key":"R118-19-20210212","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/j.1600-0897.1985.tb00334.x","article-title":"The mechanism of the inhibitory effect of progesterone on lymphocyte cytotoxicity: I. Progesterone-treated lymphocytes release a substance inhibiting cytotoxicity and prostaglandins synthesis.","volume":"9","author":"Szekeres-Bartho","year":"1985","journal-title":"Am J Reprod Immunol Microbiol"},{"key":"R119-19-20210212","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1002\/eji.200535428","article-title":"Regulatory T cells induce a privileged tolerant microenvironment at the fetal-maternal interface.","volume":"36","author":"Zenclussen","year":"2006","journal-title":"Eur J Immunol"},{"key":"R120-19-20210212","doi-asserted-by":"crossref","first-page":"4562","DOI":"10.4049\/jimmunol.151.9.4562","article-title":"Synthesis of T helper 2-type cytokines at the maternal-fetal interface.","volume":"151","author":"Lin","year":"1993","journal-title":"J Immunol"},{"key":"R121-19-20210212","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1038\/2006","article-title":"Defective production of both leukemia inhibitory factor and type 2 T-helper cytokines by decidual T cells in unexplained recurrent abortions.","volume":"4","author":"Piccinni","year":"1998","journal-title":"Nat Med"},{"key":"R122-19-20210212","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0165-0378(00)00060-7","article-title":"Cytokine network at the feto-maternal interface.","volume":"47","author":"Saito","year":"2000","journal-title":"J Reprod Immunol"},{"key":"R123-19-20210212","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1097\/GRF.0b013e31822730b9","article-title":"Thyroid autoantibodies and pregnancy outcomes.","volume":"54","author":"Abbassi-Ghanavati","year":"2011","journal-title":"Clin Obstet Gynecol"},{"key":"R124-19-20210212","doi-asserted-by":"crossref","first-page":"J275","DOI":"10.1016\/j.jaut.2011.11.014","article-title":"Pathogenesis of infertility and recurrent pregnancy loss in thyroid autoimmunity.","volume":"38","author":"Twig","year":"2012","journal-title":"J Autoimmun"},{"key":"R125-19-20210212","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1136\/gutjnl-2011-301346","article-title":"The Oslo definitions for celiac disease and related terms.","volume":"62-","author":"Ludvigsson","year":"2013","journal-title":"Gut"},{"key":"R126-19-20210212","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.gastro.2005.05.065","article-title":"Celiac disease and risk of adverse fetal outcome: a population-based cohort study.","volume":"129","author":"Ludvigsson","year":"2005","journal-title":"Gastroenterology"},{"key":"R127-19-20210212","doi-asserted-by":"crossref","first-page":"2925","DOI":"10.1007\/s10620-008-0242-x","article-title":"Effect of gluten-free diet on pregnancy outcome in celiac disease patients with recurrent miscarriages.","volume":"53","author":"Tursi","year":"2008","journal-title":"Dig Dis Sci"},{"key":"R128-19-20210212","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1097\/01.OGX.0000109223.04391.9D","article-title":"Subfertility and gastrointestinal disease: unexplained is often undiagnosed.","volume":"59","author":"Bradley","year":"2004","journal-title":"Obstet Gynecol Surv"},{"key":"R129-19-20210212","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1016\/j.fertnstert.2010.11.005","article-title":"Latent celiac disease in reproductive performance of women.","volume":"95","author":"Kumar","year":"2011","journal-title":"Fertil Steril"},{"key":"R130-19-20210212","doi-asserted-by":"crossref","first-page":"2896","DOI":"10.1093\/humrep\/der263","article-title":"Risk of endometriosis in 11,000 women with celiac disease.","volume":"26","author":"Stephansson","year":"2011","journal-title":"Hum Reprod"},{"key":"R131-19-20210212","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1538-7836.2006.01753.x","article-title":"International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS).","volume":"4","author":"Miyakis","year":"2006","journal-title":"J Thromb Haemost"},{"key":"R132-19-20210212","first-page":"39","article-title":"Is obstetric antiphospholipid syndrome a primary nonthrombotic, proinflammatory, complement-mediated disorder related to antiphospholipid antibodies Obstet Gynecol Surv.","volume":"65","author":"Alijotas-Reig","year":"2010","journal-title":""},{"key":"R133-19-20210212","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.autrev.2011.10.006","article-title":"Obstetric antiphospholipid syndrome.","volume":"11","author":"Galarza-Maldonado","year":"2012","journal-title":"Autoimmun Rev"},{"key":"R134-19-20210212","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1111\/j.1471-0528.1986.tb07830.x","article-title":"Inadequate maternal vascular response to placentation in pregnancies complicated by pre-eclampsia and by small-for-gestational age infants.","volume":"93","author":"Khong","year":"1986","journal-title":"Br J Obstet Gynaecol"},{"key":"R135-19-20210212","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1055\/s-0037-1614001","article-title":"Antiphospholipid and antiprotein syndromes in non-thrombotic, non-autoimmune women with unexplained recurrent primary early foetal loss. The Nimes Obstetricians and Haematologists Study-NOHA.","volume":"84","author":"Gris","year":"2000","journal-title":"Thromb Haemost"},{"key":"R136-19-20210212","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1160\/TH09-01-0043","article-title":"Laboratory criteria of the obstetrical antiphospholipid syndrome. Data from a multicentric prospective European women cohort.","volume":"102","author":"Boffa","year":"2009","journal-title":"Thromb Haemost"},{"key":"R137-19-20210212","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1177\/0961203312440058","article-title":"The European Registry on Obstetric Antiphospholipid Syndrome (EUROAPS). A preliminary first year report.","volume":"21","author":"Alijotas-Reig","year":"2012","journal-title":"Lupus"},{"key":"R138-19-20210212","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1177\/0961203309361484","article-title":"Obstetric antiphospholipid sydrome: still a challenge.","volume":"19","author":"Levy","year":"2010","journal-title":"Lupus"},{"key":"R139-19-20210212","first-page":"32","article-title":"Frequency of antiphospholipid antibodies and antiphospholipid syndrome in women with recurrent miscarriages.","volume":"82","author":"Rajewski","year":"2011","journal-title":"Ginekol Pol"},{"key":"R140-19-20210212","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.bpobgyn.2011.10.006","article-title":"Antiphospholipid syndrome in obstetrics.","volume":"26","author":"Danza","year":"2012","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"R141-19-20210212","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1016\/0002-9378(89)90858-2","article-title":"Reproductive failure because autoantibodies: unexplained infertility and pregnancy wastage.","volume":"160","author":"Gleicher","year":"1989","journal-title":"Am J Obstet Gynecol"},{"key":"R142-19-20210212","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1034\/j.1600-0897.2002.01111.x","article-title":"Some thoughts on the reproductive autoimmune failure syndrome (RAFS) and Th-1 versus Th-2 immune responses.","volume":"48","author":"Gleicher","year":"2002","journal-title":"Am J Reprod Immunol"},{"key":"R143-19-20210212","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/0002-9378(88)90525-X","article-title":"The reproductive autoimmune failure syndrome.","volume":"159","author":"Gleicher","year":"1988","journal-title":"Am J Obstet Gynecol"},{"key":"R144-19-20210212","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1093\/rheumatology\/38.6.485","article-title":"Reproductive failure prior to the onset of clinical autoimmune disease.","volume":"38","author":"Gleicher","year":"1999","journal-title":"Rheumatology (Oxford)"},{"key":"R145-19-20210212","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.bpobgyn.2011.10.002","article-title":"Thrombophilia and early pregnancy loss.","volume":"26","author":"McNamee","year":"2012","journal-title":"Best Pract Res Clin Obstet Gynecol"},{"key":"R146-19-20210212","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1160\/TH07-05-0373","article-title":"Thrombophilias and adverse pregnancy outcomea confounded problem!","volume":"99","author":"Kist","year":"2008","journal-title":"Thromb Haemost"},{"key":"R147-19-20210212","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1055\/s-0031-1293207","article-title":"Testing for inherited thrombophilia in recurrent miscarriage.","volume":"29","author":"De Jong","year":"2011","journal-title":"Semin Reprod Med"},{"key":"R148-19-20210212","doi-asserted-by":"crossref","first-page":"2176","DOI":"10.1111\/j.1538-7836.2005.01609.x","article-title":"Thrombophilia and pregnancy loss in first intended pregnancy.","volume":"3","author":"Brenner","year":"2005","journal-title":"J Thromb Haemost"},{"key":"R149-19-20210212","first-page":"45","article-title":"Severe preeclampsia and high frequency of genetic thrombophilic mutations.","volume":"96","author":"Kupferminc","year":"2000","journal-title":"Obstet Gynecol"},{"key":"R150-19-20210212","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1055\/s-2003-38831","article-title":"Thrombophilia and fetal loss.","volume":"29","author":"Brenner","year":"2003","journal-title":"Semin Thromb Haemost"},{"key":"R151-19-20210212","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1056\/NEJM200002103420610","article-title":"The challenge of thrombophilia in maternal-fetal medicine.","volume":"342","author":"Greer","year":"2000","journal-title":"N Engl J Med"},{"key":"R152-19-20210212","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/S1521-6926(02)00097-X","article-title":"Inherited thrombophilia and pregnancy loss.","volume":"16","author":"Brenner","year":"2003","journal-title":"Best Pract Res Clin Haematol"},{"key":"R153-19-20210212","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1111\/j.1600-0897.2008.00630.x","article-title":"Paternal thrombophilic gene mutations are not associated with recurrent miscarriage.","volume":"60","author":"Toth","year":"2008","journal-title":"Am J Reprod Immunol"},{"key":"R155-19-20210212","first-page":"37","article-title":"Prognosis for live birth in women with recurrent miscarriage: what is the best measure of success Obstet Gynecol.","volume":"119","author":"Lund","year":"2012","journal-title":""},{"key":"R157-19-20210212","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s10897-005-3241-5","article-title":"Genetic evaluation and counseling of couples with recurrent miscarriage: recommendations of the National Society of Genetic Counselors.","volume":"14","author":"Laurino","year":"2005","journal-title":"J Genet Couns"},{"key":"R158-19-20210212","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/S0015-0282(00)01801-X","article-title":"Karyotype of the abortus in recurrent miscarriage.","volume":"75","author":"Carp","year":"2001","journal-title":"Fertil Steril"},{"key":"R159-19-20210212","doi-asserted-by":"crossref","first-page":"2849","DOI":"10.1093\/humrep\/deh536","article-title":"Comparison of blastocyst transfer with or without preimplantation genetic diagnosis for aneuploidy screening in couples with advanced maternal age: a prospective randomized controlled trial.","volume":"19","author":"Staessen","year":"2004","journal-title":"Hum Reprod"},{"key":"R160-19-20210212","doi-asserted-by":"crossref","first-page":"2818","DOI":"10.1093\/humrep\/den367","article-title":"Preimplantation genetic screening does not improve delivery rate in women under the age of 36 following single-embryo transfer.","volume":"23","author":"Staessen","year":"2008","journal-title":"Hum Reprod"},{"key":"R161-19-20210212","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1093\/humupd\/dmr011","article-title":"Reproductive outcome after PGD in couples with recurrent miscarriage carrying a structural chromosome abnormality: a systematic review.","volume":"17","author":"Franssen","year":"2011","journal-title":"Hum Reprod Update"},{"key":"R162-19-20210212","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s10815-011-9654-1","article-title":"Preimplantation genetic diagnosis for couples with a Robertsonian translocation: practical information for genetic counseling.","volume":"29","author":"Chang","year":"2012","journal-title":"J Assist Reprod Genet"},{"key":"R163-19-20210212","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1093\/humupd\/dms007","article-title":"Treatment of thyroid disorders before conception and in early pregnancy: a systematic review.","volume":"18","author":"Vissenberg","year":"2012","journal-title":"Hum Reprod Update"},{"key":"R164-19-20210212","first-page":"CD003511","article-title":"Progestogen for preventing miscarriage.","volume":"4","author":"Oates-Whitehead","year":"2003","journal-title":"Cochrane Database Syst Rev"},{"key":"R165-19-20210212","first-page":"CD003511","article-title":"Progestogen for preventing miscarriage.","volume":"2","author":"Haas","year":"2008","journal-title":"Cochrane Database Syst Rev"},{"key":"R166-19-20210212","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1093\/humupd\/dmm035","article-title":"Progestagen therapy for recurrent miscarriage.","volume":"14","author":"Szekeres-Bartho","year":"2008","journal-title":"Hum Reprod Update"},{"key":"R168-19-20210212","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/S0015-0282(98)00164-2","article-title":"Hyperprolactinemic recurrent miscarriage and results of randomized bromocriptine treatment trials.","volume":"70","author":"Hirahara","year":"1998","journal-title":"Fertil Steril"},{"key":"R169-19-20210212","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1080\/09513590802585589","article-title":"Pregnancy rate following bromocriptine treatment in infertile women with galactorrhea.","volume":"25","author":"Eftekhari","year":"2009","journal-title":"Gynecol Endocrinol"},{"key":"R170-19-20210212","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1080\/13625180801920032","article-title":"Hysteroscopy in the evaluation of habitual abortions.","volume":"13","author":"Dendrinos","year":"2008","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"R171-19-20210212","doi-asserted-by":"crossref","first-page":"14","DOI":"10.3109\/13645706.2010.496999","article-title":"See and treat hysteroscopy after missed abortion.","volume":"20","author":"Kuzel","year":"2011","journal-title":"Minim Invasive Ther Allied Technol"},{"key":"R172-19-20210212","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0301-2115(99)00126-8","article-title":"Hysteroscopic metroplasty for septate uterus and repetitive abortions: reproductive outcome.","volume":"88","author":"Porcu","year":"2000","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"R173-19-20210212","first-page":"110","article-title":"Septate uterus: reproductive outcome after hysteroscopic metroplasty.","volume":"33","author":"Pace","year":"2006","journal-title":"Clin Exp Obstet Gynecol"},{"key":"R174-19-20210212","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1097\/GCO.0b013e32833e124e","article-title":"Recent thoughts on management and prevention of recurrent early pregnancy loss.","volume":"22","author":"Tang","year":"2010","journal-title":"Curr Opin Obstet Gynecol"},{"key":"R175-19-20210212","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1007\/s00404-010-1531-0","article-title":"Reproductive outcome following hysteroscopic myomectomy in patients with infertility and recurrent abortions.","volume":"282","author":"Roy","year":"2010","journal-title":"Arch Gynecol Obstet"},{"key":"R176-19-20210212","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0301-2115(03)00159-3","article-title":"Reproductive outcome before and after laparoscopic or abdominal myomectomy for subserous or intramural myomas.","volume":"110","author":"Campo","year":"2003","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"R177-19-20210212","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1016\/j.fertnstert.2008.01.051","article-title":"Fibroids and infertility: an updated systematic review of the evidence.","volume":"91","author":"Pritts","year":"2009","journal-title":"Fertil Steril"},{"key":"R178-19-20210212","first-page":"207","article-title":"Intra-uterine adhesions and fertility outcome: how to optimize success Curr Opin Obstet Gynecol.","volume":"19","author":"Kodaman","year":"2007","journal-title":""},{"key":"R180-19-20210212","first-page":"57","article-title":"Chlamydia trachomatis infection during pregnancy: known unknowns.","volume":"12","author":"Howie","year":"2011","journal-title":"Discov Med"},{"key":"R181-19-20210212","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1016\/S0002-9378(96)70610-5","article-title":"Antiphospholipid antibody-associated recurrent pregnancy loss: treatment with heparin and low-dose aspirin is superior to low-dose aspirin alone.","volume":"174","author":"Kutteh","year":"1996","journal-title":"Am J Obstet Gynecol"},{"key":"R182-19-20210212","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1111\/j.1600-0897.1996.tb00501.x","article-title":"A clinical trial for the treatment of antiphospholipid antibody-associated recurrent pregnancy loss with lower dose heparin and aspirin.","volume":"35","author":"Kutteh","year":"1996","journal-title":"Am J Reprod Immunol"},{"key":"R183-19-20210212","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1136\/bmj.314.7076.253","article-title":"Randomised controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies.","volume":"314","author":"Rai","year":"1997","journal-title":"BMJ"},{"key":"R184-19-20210212","first-page":"408","article-title":"Antiphospholipid syndrome in pregnancy: a randomized, controlled trial of treatment.","volume":"100","author":"Farquarson","year":"2002","journal-title":"Obstet Gynecol"},{"key":"R185-19-20210212","doi-asserted-by":"crossref","first-page":"2981","DOI":"10.1093\/humrep\/17.11.2981","article-title":"Antiphospholipid antibodies (APA) and recurrent pregnancy loss: treating a unique APA positive population.","volume":"17","author":"Franklin","year":"2002","journal-title":"Hum Reprod"},{"key":"R186-19-20210212","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/S1701-2163(16)30644-2","article-title":"Treatment of antiphospholipid antibody syndrome in pregnancy: a randomized pilot trial comparing treatment with low-molecular weight heparin to unfractionated heparin.","volume":"26","author":"Stephenson","year":"2004","journal-title":"J Obstet Gynecol Can"},{"key":"R187-19-20210212","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/j.fertnstert.2004.11.002","article-title":"Antiphospholipid antibodies associated with recurrent pregnancy loss: prospective, multicenter, controlled pilot study comparing treatment with low-molecular weight heparin versus unfractionated heparin.","volume":"83","author":"Noble","year":"2005","journal-title":"Fertil Steril"},{"key":"R188-19-20210212","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1093\/rheumatology\/kep373","article-title":"Combination of heparin and aspirin is superior to aspirin alone in enhancing live births in patients with recurrent pregnancy loss and positive anti-phospholipid antibodies: a meta-analysis of randomized controlled trials and meta-regression.","volume":"49","author":"Mak","year":"2010","journal-title":"Rheumatology"},{"key":"R189-19-20210212","doi-asserted-by":"crossref","first-page":"471","DOI":"10.2298\/MPNS1110471M","article-title":"Thromboprophylaxis implementation during pregnancy in women with recurrent foetal losses and thrombophilia.","volume":"64","author":"Mitic","year":"2011","journal-title":"Med Pregl"},{"key":"R190-19-20210212","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1097\/BOR.0b013e328344c3f7","article-title":"Heparin or aspirin or both in the treatment of recurrent abortions in women with antiphospholipid antibody (syndrome).","volume":"23","author":"Hoppe","year":"2011","journal-title":"Curr Opin Rheumatol"},{"key":"R191-19-20210212","doi-asserted-by":"crossref","first-page":"842","DOI":"10.3109\/01443615.2010.518651","article-title":"Efficacy and safety of two doses of low molecular weight heparin (enoxaparin) in pregnant women with a history of recurrent abortion secondary to antiphospholipid syndrome.","volume":"30","author":"Fouda","year":"2010","journal-title":"J Obstet Gynaecol"},{"key":"R192-19-20210212","doi-asserted-by":"crossref","first-page":"338S","DOI":"10.1378\/chest.126.3_suppl.338S","article-title":"Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.","volume":"126","author":"Geerts","year":"2004","journal-title":"Chest"},{"key":"R193-19-20210212","doi-asserted-by":"crossref","first-page":"844S","DOI":"10.1378\/chest.08-0761","article-title":"Venous thromboembolism, thrombophilias, antithrombotic therapy, and pregnancy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th edn).","volume":"133","author":"Bates","year":"2008","journal-title":"Chest"},{"key":"R194-19-20210212","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1177\/1076029607306400","article-title":"Successful pregnancy outcome in women with bad obstetric history and recurrent fetal loss due to thrombophilia: effect of unfractionated heparin and low-molecular weight heparin.","volume":"14","author":"Ghosh","year":"2008","journal-title":"Clin Appl Thromb Hemost"},{"key":"R195-19-20210212","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1111\/j.1365-2141.2012.09112.x","article-title":"Pregnancy loss and thrombophilia: the elusive link.","volume":"157","author":"Bennett","year":"2012","journal-title":"Br J Haematol"},{"key":"R196-19-20210212","doi-asserted-by":"crossref","first-page":"279","DOI":"10.3899\/jrheum.080763","article-title":"Low molecular weight heparin and aspirin for recurrent pregnancy loss: results from the randomized, controlled HepASA Trial.","volume":"36","author":"Laskin","year":"2009","journal-title":"J Rheumatol"},{"key":"R197-19-20210212","doi-asserted-by":"crossref","first-page":"2868","DOI":"10.1093\/humrep\/14.11.2868","article-title":"A longitudinal study of pregnancy outcome following idiopathic recurrent miscarriage.","volume":"14","author":"Brigham","year":"1999","journal-title":"Hum Reprod"},{"key":"R198-19-20210212","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1093\/humrep\/der021","article-title":"Supportive care for women with unexplained recurrent miscarriage: patients perspectives.","volume":"26","author":"Musters","year":"2011","journal-title":"Hum Reprod"},{"key":"R199-19-20210212","doi-asserted-by":"crossref","first-page":"2761","DOI":"10.1182\/blood-2003-10-3614","article-title":"Apoptotic bodies from endothelial cells enhance the number and initiate the differentiation of human endothelial progenitor cells in vitro.","volume":"104","author":"Hristov","year":"2004","journal-title":"Blood"},{"key":"R200-19-20210212","doi-asserted-by":"crossref","first-page":"3337","DOI":"10.1002\/art.21350","article-title":"Microparticles as regulators of inflammation.","volume":"52","author":"Distler","year":"2005","journal-title":"Arthritis Rheum"},{"key":"R201-19-20210212","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1055\/s-0037-1613378","article-title":"Circulating microparticles: a marker of procoagulant state in normal pregnancy and pregnancy complicated by preeclampsia or intrauterine growth restriction.","volume":"89","author":"Bretelle","year":"2003","journal-title":"Thromb Haemost"},{"key":"R202-19-20210212","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.ejogrb.2009.04.002","article-title":"Circulating microparticles, lupus anticoagulant and recurrent miscarriages.","volume":"145","author":"Alijotas-Reig","year":"2009","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"R203-19-20210212","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1016\/j.ajog.2004.06.044","article-title":"Elevated plasma endothelial microparticles: preeclampsia versus gestational hypertension.","volume":"191","author":"Gonzalez-Quintero","year":"2004","journal-title":"Am J Obstet Gynecol"},{"key":"R204-19-20210212","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1111\/j.1600-0897.2010.00972.x","article-title":"Circulating cell-derived microparticles in women with pregnancy loss.","volume":"66","author":"Alijotas-Reig","year":"2011","journal-title":"Am J Reprod Immunol"},{"key":"R205-19-20210212","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.ijgo.2008.04.007","article-title":"Platelet-derived microparticles levels in women with recurrent spontaneous abortion.","volume":"102","author":"Kaptan","year":"2008","journal-title":"Int J Gynecol Obstet"},{"key":"R206-19-20210212","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1055\/s-0030-1270342","article-title":"The functions of microparticles in pre-eclampsia.","volume":"37","author":"van der Post","year":"2011","journal-title":"Semin Thromb Hemost"},{"key":"R207-19-20210212","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1111\/j.1600-0897.2011.01072.x","article-title":"Circulating cell-derived microparticles in severe preeclampsia and in fetal growth restriction.","volume":"67","author":"Alijotas-Reig","year":"2012","journal-title":"Am J Reprod Immunol"},{"key":"R208-19-20210212","first-page":"531","article-title":"Is the endothelial circulating microparticles analysis enough to assess the inflammatory status related to preeclampsia Med Clin (Barc).","volume":"136","author":"Alijotas-Reig","year":"2011","journal-title":""},{"key":"R209-19-20210212","first-page":"199","article-title":"Stimulation trials of trophoblast cells in vitro using PP14.","volume":"200","author":"Jeschke","year":"1996","journal-title":"Z Geburtshilfe Neonatol"},{"key":"R210-19-20210212","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1515\/JPM.2005.039","article-title":"Stimulation of hCG protein and mRNA in first trimester villous cytotrophoblast cells in vitro by glycodelin A.","volume":"33","author":"Jeschke","year":"2005","journal-title":"J Perinat Med"},{"key":"R211-19-20210212","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1369\/jhc.2008.950600","article-title":"Glycodelin protein and mRNA is downregulated in human first trimester abortion and partially upregulated in mole pregnancy.","volume":"56","author":"Toth","year":"2008","journal-title":"J Histochem Cytochem"},{"key":"R212-19-20210212","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.ejogrb.2006.09.005","article-title":"A comparative study of glycodelin concentrations in uterine flushings in women with subseptate uteri, history of unexplained recurrent miscarriage and healthy controls.","volume":"133","author":"Salim","year":"2007","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"R213-19-20210212","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1055\/s-2005-864115","article-title":"Stimulation of HCG, estrogen and progesterone production in isolated trophoblast cells by glycodelin A or its N-glycans.","volume":"209","author":"Jeschke","year":"2005","journal-title":"Z Geburtshilfe Neonatol"},{"key":"R214-19-20210212","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s00404-004-0682-2","article-title":"Glycodelin A and differentiation of first trimester trophoblast cells in vitro.","volume":"272","author":"Jeschke","year":"2005","journal-title":"Arch Gynecol Obstet"},{"key":"R215-19-20210212","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/s00418-003-0529-0","article-title":"Glycodelin and amniotic fluid transferrin as inhibitors of E-selectin-mediated cell adhesion.","volume":"119","author":"Jeschke","year":"2003","journal-title":"Histochem Cell Biol"},{"key":"R216-19-20210212","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1093\/glycob\/cws104","article-title":"Galectin-1 confers immune privilege to human trophoblast: implications in recurrent fetal loss.","volume":"22","author":"Ramhorst","year":"2012","journal-title":"Glycobiology"},{"key":"R217-19-20210212","doi-asserted-by":"crossref","first-page":"5488","DOI":"10.4049\/jimmunol.0803177","article-title":"Human chorionic gonadotropin attracts regulatory T cells into the fetal-maternal interface during early human pregnancy.","volume":"182","author":"Schumacher","year":"2009","journal-title":"J Immunol"},{"key":"R218-19-20210212","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.jri.2012.01.001","article-title":"Hyperglycosylated hCG and pregnancy failures.","volume":"93","author":"Cole","year":"2012","journal-title":"J Reprod Immunol"},{"key":"R219-19-20210212","doi-asserted-by":"crossref","first-page":"712","DOI":"10.3109\/09513590.2010.488779","article-title":"Recurrent miscarriage and hCG supplementation: a review and metaanalysis.","volume":"26","author":"Carp","year":"2010","journal-title":"Gynecol Endocrinol"},{"key":"R220-19-20210212","first-page":"1020","article-title":"Expression of placental leptin and leptin receptor transcripts in early pregnancy and at term.","volume":"92","author":"Henson","year":"1998","journal-title":"Obstet Gynecol"},{"key":"R221-19-20210212","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1046\/j.1365-2265.1999.00637.x","article-title":"Serum leptin levels in women throughout pregnancy and the postpartum period in women suffering spontaneous abortion.","volume":"50","author":"Lage","year":"1999","journal-title":"Clin Endocrinol (Oxf)"},{"key":"R222-19-20210212","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1097\/00001703-200012000-00008","article-title":"Leptin and pregnancy outcome.","volume":"12","author":"Kratzch","year":"2000","journal-title":"Curr Opin Obstet Gynecol"},{"key":"R223-19-20210212","doi-asserted-by":"crossref","first-page":"167","DOI":"10.33549\/physiolres.930599","article-title":"Leptin, soluble leptin receptor and leptin gene polymorphism in relation to preeclampsia risk.","volume":"54","author":"Muy-Rivera","year":"2005","journal-title":"Physiol Res"},{"key":"R224-19-20210212","doi-asserted-by":"crossref","first-page":"2341","DOI":"10.2337\/diabetes.51.8.2341","article-title":"The peroxisome proliferator-activated receptor-gamma2 Pro12Ala polymorphism.","volume":"51","author":"Stumvoll","year":"2002","journal-title":"Diabetes"},{"key":"R225-19-20210212","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.placenta.2006.04.009","article-title":"PPARs and the placenta.","volume":"28","author":"Fournier","year":"2007","journal-title":"Placenta"},{"key":"R226-19-20210212","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.1600-0897.2007.00514.x","article-title":"Peroxisome proliferator-activated receptors: new players in the field of reproduction.","volume":"58","author":"Toth","year":"2007","journal-title":"Am J Reprod Immunol"},{"key":"R227-19-20210212","doi-asserted-by":"crossref","first-page":"3334","DOI":"10.1210\/en.2005-0406","article-title":"Leptin and adiponectin stimulate the release of proinflammatory cytokines and prostaglandins from human placenta and maternal adipose tissue via nuclear factor-kappaB, peroxisomal proliferator-activated receptor-gamma and extracellularly regulated kinase 12.","volume":"146","author":"Lappas","year":"2005","journal-title":"Endocrinology"},{"key":"R228-19-20210212","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.jri.2009.10.012","article-title":"Glycoprotein and carbohydrate binding protein expression in the placenta in early pregnancy loss.","volume":"85","author":"Jeschke","year":"2010","journal-title":"J Reprod Immunol"},{"key":"R229-19-20210212","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1093\/molehr\/gah044","article-title":"Decidual and peripheral blood CD4CD25 regulatory T cells in early pregnancy subjects and spontaneous abortion cases.","volume":"10","author":"Sasaki","year":"2004","journal-title":"Mol Human Reprod"},{"key":"R230-19-20210212","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1093\/humrep\/der164","article-title":"Natural killer cells and pregnancy outcomes in women with recurrent miscarriage and infertility: a systematic review.","volume":"26","author":"Tang","year":"2011","journal-title":"Hum Reprod"},{"key":"R231-19-20210212","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/BF01546317","article-title":"Cytokine measurements and interpretation of cytokine assays in human disease.","volume":"14","author":"Whiteside","year":"1994","journal-title":"J Clin Immunol"},{"key":"R232-19-20210212","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1084\/jem.20030305","article-title":"Human decidual natural killer cells are a unique NK cell subset with immunomodulatory potential.","volume":"198","author":"Koopman","year":"2003","journal-title":"J Exp Med"},{"key":"R233-19-20210212","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1093\/humrep\/den011","article-title":"Association of maternal killer-cell immunoglobulin-like receptors and parental HLA-C genotypes with recurrent miscarriage.","volume":"23","author":"Hiby","year":"2008","journal-title":"Hum Reprod"},{"key":"R234-19-20210212","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1093\/humrep\/dep217","article-title":"Reply: influence of activating and inhibiting killer immunoglobulinlike receptors on predisposition to recurrent miscarriages.","volume":"24","author":"Faridi","year":"2009","journal-title":"Hum Reprod"},{"key":"R235-19-20210212","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1093\/rheumatology\/kem197","article-title":"High levels of NK cells in the peripheral blood of patients affected with anti-phospholipid syndrome and recurrent spontaneous abortion: a potential new hypothesis.","volume":"46","author":"Perricone","year":"2007","journal-title":"Rheumatology (Oxford)"},{"key":"R236-19-20210212","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/j.1600-0897.2008.00585.x","article-title":"Treatment with tumor necrosis factor inhibitors and intravenous immunoglobulin improves live births rates in women with recurrent spontaneous abortion.","volume":"60","author":"Winger","year":"2008","journal-title":"Am J Reprod Immunol"},{"key":"R237-19-20210212","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1111\/j.1600-0897.2008.00669.x","article-title":"Treatment with adalimumab (Humira) and intravenous immunoglobulin improves pregnancy rates in women undergoing IVF.","volume":"61","author":"Winger","year":"2009","journal-title":"Am J Reprod Immunol"},{"key":"R238-19-20210212","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jri.2010.01.007","article-title":"Anti-TNFalpha therapy in immune-mediated subfertility: state of the art. J.","volume":"85","author":"Clark","year":"2010","journal-title":"Reprod Immunol"},{"key":"R239-19-20210212","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1111\/j.1600-0897.2007.00536.x","article-title":"Results of immunotherapy for patients with unexplained primary recurrent abortionsprospective non-randomized cohort study.","volume":"58","author":"Nonaka","year":"2007","journal-title":"Am J Reprod Immunol"},{"key":"R240-19-20210212","first-page":"CD000112","article-title":"Immunotherapy for recurrent miscarriage.","volume":"1","author":"Scott","year":"2003","journal-title":"Cochrane Database Syst Rev"},{"key":"R241-19-20210212","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.2146\/ajhp070582","article-title":"Unlabeled uses of intravenous immune globulin.","volume":"65","author":"Leong","year":"2008","journal-title":"Am J Health Syst Pharm"},{"key":"R242-19-20210212","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1093\/humrep\/17.3.809","article-title":"A randomized, double-blind, placebo-controlled trial of intravenous immunoglobulin in the prevention of recurrent miscarriage: evidence for a therapeutic effect in women with secondary recurrent miscarriage.","volume":"17","author":"Christiansen","year":"2002","journal-title":"Hum Reprod"},{"key":"R243-19-20210212","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1111\/j.1600-0897.2007.00529.x","article-title":"Decline in number of elevated blood CD3() CD56() NKT cells in response to intravenous immunoglobulin treatment correlates with successful pregnancy.","volume":"58","author":"van den Heuvel","year":"2007","journal-title":"Am J Reprod Immunol"},{"key":"R244-19-20210212","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1093\/humupd\/7.5.501","article-title":"Unexplained sporadic and recurrent miscarriage in the new millennium: a critical analysis of immune mechanisms and treatments.","volume":"7","author":"Clark","year":"2001","journal-title":"Hum Reprod Update"},{"key":"R245-19-20210212","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.jri.2009.12.006","article-title":"Recurrent miscarriage: current concepts in diagnosis and treatment.","volume":"85","author":"Toth","year":"2010","journal-title":"J Reprod Immunol"},{"key":"R246-19-20210212","doi-asserted-by":"crossref","first-page":"2703","DOI":"10.1093\/humrep\/dep240","article-title":"Use of granulocyte colony-stimulating factor for the treatment of unexplained recurrent miscarriage: a randomised controlled trial.","volume":"24","author":"Scarpellini","year":"2009","journal-title":"Hum Reprod"},{"key":"R247-19-20210212","first-page":"117","article-title":"Disorders of implantation are there diagnostic and therapeutic options J Reprod Immunol.","volume":"90","author":"Toth","year":"2011","journal-title":""},{"key":"R248-19-20210212","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1186\/1745-6215-10-102","article-title":"Prednisolone trial: study protocol for a randomised controlled trial of prednisolone for women with idiopathic recurrent miscarriage and raised levels of uterine natural killer (uNK) cells in the endometrium.","volume":"10","author":"Tang","year":"2009","journal-title":"Trials"},{"key":"R249-19-20210212","doi-asserted-by":"crossref","first-page":"6948","DOI":"10.1182\/blood-2011-02-339234","article-title":"First-trimester low-dose prednisolone in refractory antiphospholipid antibody-related pregnancy loss.","volume":"117","author":"Bramham","year":"2011","journal-title":"Blood"},{"key":"R250-19-20210212","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1093\/humrep\/15.3.612","article-title":"Polycystic ovaries and recurrent miscarriages- a reappraisal.","volume":"15","author":"Rai","year":"2000","journal-title":"Hum Reprod"},{"key":"R251-19-20210212","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1056\/NEJMoa063971","article-title":"Clomiphene, metformin, or both for infertility in the polycystic ovary syndrome.","volume":"356","author":"Legro","year":"2007","journal-title":"N Engl J Med"},{"key":"R252-19-20210212","first-page":"CD004734","article-title":"Aspirin or anticoagulants for treating recurrent miscarriage in women without antiphospholipid syndrome.","volume":"21","author":"Kaandorp","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"key":"R253-19-20210212","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1056\/NEJMoa1000641","article-title":"Aspirin plus heparin or aspirin alone in women with recurrent miscarriage.","volume":"362","author":"Kaandorp","year":"2010","journal-title":"N Engl J Med"},{"key":"R254-19-20210212","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s00404-007-0527-x","article-title":"Treatment options and pregnancy outcome in women with idiopathic recurrent miscarriages: a placebo-controlled study.","volume":"278","author":"Fawzy","year":"2008","journal-title":"Arch Gynecol Obstet"},{"key":"R255-19-20210212","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1080\/01443610802042688","article-title":"Low-molecular weight heparin in patients with recurrent early miscarriages of unknown aetiology.","volume":"28","author":"Badawy","year":"2008","journal-title":"J Obstet Gynaecol"},{"key":"R257-19-20210212","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1097\/GRF.0b013e318161719c","article-title":"Genetics of pregnancy loss.","volume":"51","author":"Warren","year":"2008","journal-title":"Clin Obstet Gynecol"}],"container-title":["Obstetrical & Gynecological Survey"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/OGX.0b013e31828aca19","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,11]],"date-time":"2024-05-11T02:20:39Z","timestamp":1715394039000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00006254-201306000-00019"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,6]]},"references-count":251,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1097\/ogx.0b013e31828aca19","relation":{},"ISSN":["0029-7828"],"issn-type":[{"value":"0029-7828","type":"print"}],"subject":[],"published":{"date-parts":[[2013,6]]}}}